Episódios

  • Dementia with Lewy Bodies and Parkinson Disease Dementia
    Nov 21 2025

    Dr. Jason Crowell and Dr. YuHong Fu discuss the importance of differentiating between dementia with Lewy bodies and Parkinson disease dementia.

    Show citatiion:

    Fu Y, Halliday GM. Dementia with Lewy bodies and Parkinson disease dementia - the same or different and is it important?. Nat Rev Neurol. 2025;21(7):394-403. doi:10.1038/s41582-025-01090-x

    Exibir mais Exibir menos
    2 minutos
  • Outcomes After RCVS With Convexity Subarachnoid Hemorrhage
    Nov 20 2025

    Dr. Dan Ackerman and Dr. Isabel Hostettler discuss the diagnosis, risk factors, and prognosis of RCVS, highlighting the need to recognize symptoms and distinguish it from other causes of subarachnoid hemorrhage.

    Show reference:

    Hostettler IC, Ponciano A, Wilson D, et al. Outcomes After Reversible Cerebral Vasoconstriction Syndrome With Convexity Subarachnoid Hemorrhage: Individual Patient Data Analysis. Neurology. 2025;105(5):e213984. doi:10.1212/WNL.0000000000213984

    Exibir mais Exibir menos
    4 minutos
  • November President Spotlight: Medicare 2026 Rulemaking
    Nov 19 2025

    In the November episode of the President's Spotlight, Dr. Jason Crowell talks with Dr. Natalia Rost about the Centers for Medicare & Medicaid Services final rule for how physicians are reimbursed in 2026.

    Show reference:

    https://www.aan.com/about-the-aan/presidents-spotlight

    Exibir mais Exibir menos
    4 minutos
  • Safety and Efficacy of Nipocalimab in Adults With Generalized Myasthenia Gravis (Vivacity-MG3)
    Nov 18 2025

    Dr. Aaron Zelikovich discusses a recent article on nipocalimab and its role in treating generalized myasthenia gravis.

    Show citations:

    Antozzi C, Vu T, Ramchandren S, et al. Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study. Lancet Neurol. 2025;24(2):105-116. doi:10.1016/S1474-4422(24)00498-8

    Exibir mais Exibir menos
    3 minutos
  • Interpreting Cerebrospinal Fluid in the 2024 McDonald Criteria Revisions
    Nov 17 2025

    Dr. Katherine Havard Coiro discusses the 2024 McDonald Criteria for Multiple Sclerosis and how to interpret cerebrospinal fluid.

    Show reference:

    Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Montalban, Xavier, et al. The Lancet Neurology, Volume 24, Issue 10, 850 - 865

    Exibir mais Exibir menos
    2 minutos
  • Women History Minute - Marcelle Lapicque
    Nov 14 2025

    In this episode of the Neurology Minute, Dr. Alison Christy delves into another women's history minute to discuss Marcelle Lapicque.

    Exibir mais Exibir menos
    4 minutos
  • Super Refractory Status Epilepticus Diagnosis, Management, and Prognostication
    Nov 13 2025

    Dr. Alison Christy and Dr. Matthew Ryan Woodward discuss the complexities of status epilepticus, focusing on its definitions, the transition to refractory and super-refractory states, and the implications for treatment.

    Show citation:

    Woodward MR, Brown JP, Kittner SJ, et al. Super-Refractory Status Epilepticus Diagnosis, Management, and Prognostication: An International Survey Study. Neurol Clin Pract. 2025;15(5):e200520. doi:10.1212/CPJ.0000000000200520

    Exibir mais Exibir menos
    5 minutos
  • Prodromal Phase of Migraine - Part 2
    Nov 12 2025

    In the second part of this two-part series, Dr. Bradley Ong explains the four clinical phases of a typical migraine attack.

    Show citation:

    Lipton RB, Stokes J, Evans CJ, et al. Characterizing the patient experience during the prodrome phase of migraine: A qualitative study of symptoms and their timing. Headache. 2025;65(8):1355-1368. doi:10.1111/head.15024

    Exibir mais Exibir menos
    3 minutos